COVID-19

17th November 2023

Tuberculosis Surpasses COVID-19 as Most Deadly Infectious Disease

“Almost a third of newly ill patients with TB globally remain undetected or undiagnosed,” Dr. Keertan Dheda, professor of TB research at the London School of Hygiene and Tropical Medicine, wrote to The Epoch Times. This can be due to poor diagnostic techniques and difficulty accessing care.
27th January 2023

As with Covid-19, the effects of TB can linger after it is cured.

According to the World Health Organization, of the roughly 10 million people who fall ill with TB annually, over 80% survive. Unfortunately, as with long Covid, being cured of TB is not always the last hurdle and many people go on to struggle with post-TB lung disease. Tiyese Jeranji asked local experts about this sometimes-neglected area of TB care.
19th June 2020

WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients

The John Maytham Show – Published June 19, 2020 Guest: Keertan Dheda | Researcher at UCT Lung Institute https://www.capetalk.co.za/podcasts/144/the-john-maytham-show/330116/who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients